World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 2 March 2015
Main ID:  NCT02337972
Date of registration: 01/01/2015
Prospective Registration: Yes
Primary sponsor: Sheba Medical Center
Public title: Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients
Scientific title: Conjunctival Flora Patterns After Serial Intravitreal Injections Without Postinjection Topical Antibiotics in Diabetic Patients
Date of first enrolment: January 2015
Target sample size: 50
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02337972
Study type:  Interventional
Study design:  Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic  
Phase:  N/A
Countries of recruitment
Israel
Contacts
Name:     Irit Barequet, MD
Address: 
Telephone: 972-52-8305302
Email: ibarequet@yahoo.com
Affiliation: 
Name:     Irit Bareque, MD
Address: 
Telephone: 972-52-8305302
Email: ibarequet@yahoo.com
Affiliation: 
Name:     Irit Barequet, MD
Address: 
Telephone:
Email:
Affiliation:  Sheba medical center, Ophthalmology department
Key inclusion & exclusion criteria

Inclusion Criteria:

- age above 18

- patients with diabetes mellitus

- patients with diabetic macular edema

Exclusion Criteria:

- patients who had received a prior intraocular injection in either eye,

- current use of contact lenses,

- chronic use of any ophthalmic medication,

- ocular surgery within the past 6 months,

- use of systemic antibiotics within the past 6 months,

- known allergy or contraindication to povidone-iodine or proparacaine.



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Diabetic Macular Edema
Diabetic Retinopathy
Intervention(s)
Drug: povidone-iodine 4%
Primary Outcome(s)
Change of conjunctival flora and bacterial resistance [Time Frame: 4 month]
Secondary Outcome(s)
Secondary ID(s)
Sheba_Medical_Center
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Assaf-Harofeh Medical Center
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history